세계의 합성 펩티드 백신 시장 인사이트 및 예측(-2031년)

The global Synthetic Peptide Vaccine market is projected to grow from US$ 114.52 million in 2024 to US$ 189.30 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.36% during the forecast period 2025-2031.

Currently, synthetic peptide vaccines for human use are all in the research and development/trial stage, and the only commercially available vaccines are for veterinary use, mainly swine foot-and-mouth disease vaccines.

The China market for Synthetic Peptide Vaccine is estimated to increase from $ 98.24 million in 2024 to reach $ 161.82 million by 2031, at a CAGR of 7.29% during the forecast period of 2025 through 2031.

The global key manufacturers of Synthetic Peptide Vaccine include United Biomedical, CAHIC, Xinjiang Tecon, ISA Pharmaceuticals, Lytix Biopharma, Merck, OncoTherapy Science, Circio, Stemline Therapeutics, and Treos Bio, etc.

Report Includes

This report presents an overview of global market for Synthetic Peptide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Synthetic Peptide Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Synthetic Peptide Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Synthetic Peptide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Synthetic Peptide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Synthetic Peptide Vaccine sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including ISA Pharmaceuticals, Lytix Biopharma, CAHIC, United Biomedical, Merck, OncoTherapy Science, Circio, Stemline Therapeutics, and Treos Bio, etc.

Market Segmentation

By Company

• United Biomedical
• CAHIC
• Xinjiang Tecon
• ISA Pharmaceuticals
• Lytix Biopharma
• Merck
• OncoTherapy Science
• Circio
• Stemline Therapeutics
• Treos Bio

Segment by Type

• FMD Type O
• FMD Type O+A
• Others

Segment by Application

• Government Procurement
• Direct Sales

Segment by Region

US & Canada

• U.S.
• Canada
• Mexico

China

Asia (excluding China)

• Japan
• South Korea
• China Taiwan
• Southeast Asia
• India
• Australia

Europe

• Germany
• France
• U.K.
• Italy
• Russia

Middle East, Africa, Latin America

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Synthetic Peptide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Synthetic Peptide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Peptide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

• 1.1 Synthetic Peptide Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 FMD Type O
  • 1.2.3 FMD Type O+A
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Government Procurement
  • 1.3.3 Direct Sales
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 EXECUTIVE SUMMARY

• 2.1 Global Synthetic Peptide Vaccine Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Synthetic Peptide Vaccine Revenue by Region
  • 2.2.1 Global Synthetic Peptide Vaccine Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Synthetic Peptide Vaccine Revenue by Region (2020-2025)
  • 2.2.3 Global Synthetic Peptide Vaccine Revenue by Region (2026-2031)
  • 2.2.4 Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2031)
• 2.3 Global Synthetic Peptide Vaccine Sales Estimates and Forecasts 2020-2031
• 2.4 Global Synthetic Peptide Vaccine Sales by Region
  • 2.4.1 Global Synthetic Peptide Vaccine Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Synthetic Peptide Vaccine Sales by Region (2020-2025)
  • 2.4.3 Global Synthetic Peptide Vaccine Sales by Region (2026-2031)
  • 2.4.4 Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

• 3.1 Global Synthetic Peptide Vaccine Sales by Manufacturers
  • 3.1.1 Global Synthetic Peptide Vaccine Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2020-2025)
• 3.2 Global Synthetic Peptide Vaccine Revenue by Manufacturers
  • 3.2.1 Global Synthetic Peptide Vaccine Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025)
• 3.3 Global Key Players of Synthetic Peptide Vaccine, Industry Ranking in 2024
• 3.4 Global Synthetic Peptide Vaccine Sales Price by Manufacturers (2020-2025)
• 3.5 Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Base Distribution and Headquarters
• 3.6 Global Key Manufacturers of Synthetic Peptide Vaccine, Product Offered
• 3.7 Global Key Manufacturers of Synthetic Peptide Vaccine, Founded Date
• 3.8 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

• 4.1 Global Synthetic Peptide Vaccine Sales by Type
  • 4.1.1 Global Synthetic Peptide Vaccine Historical Sales by Type (2020-2025)
  • 4.1.2 Global Synthetic Peptide Vaccine Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Type (2020-2031)
• 4.2 Global Synthetic Peptide Vaccine Revenue by Type
  • 4.2.1 Global Synthetic Peptide Vaccine Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Synthetic Peptide Vaccine Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2020-2031)
• 4.3 Global Synthetic Peptide Vaccine Price by Type
  • 4.3.1 Global Synthetic Peptide Vaccine Price by Type (2020-2025)
  • 4.3.2 Global Synthetic Peptide Vaccine Price Forecast by Type (2026-2031)

5 MARKET SIZE BY APPLICATION

• 5.1 Global Synthetic Peptide Vaccine Sales by Application
  • 5.1.1 Global Synthetic Peptide Vaccine Historical Sales by Application (2020-2025)
  • 5.1.2 Global Synthetic Peptide Vaccine Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Synthetic Peptide Vaccine Sales Market Share by Application (2020-2031)
• 5.2 Global Synthetic Peptide Vaccine Revenue by Application
  • 5.2.1 Global Synthetic Peptide Vaccine Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Synthetic Peptide Vaccine Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2020-2031)
• 5.3 Global Synthetic Peptide Vaccine Price by Application
  • 5.3.1 Global Synthetic Peptide Vaccine Price by Application (2020-2025)
  • 5.3.2 Global Synthetic Peptide Vaccine Price Forecast by Application (2026-2031)

6 US & CANADA

• 6.1 US & Canada Synthetic Peptide Vaccine Market Size by Type
  • 6.1.1 US & Canada Synthetic Peptide Vaccine Sales by Type (2020-2031)
  • 6.1.2 US & Canada Synthetic Peptide Vaccine Revenue by Type (2020-2031)
• 6.2 US & Canada Synthetic Peptide Vaccine Market Size by Application
  • 6.2.1 US & Canada Synthetic Peptide Vaccine Sales by Application (2020-2031)
  • 6.2.2 US & Canada Synthetic Peptide Vaccine Revenue by Application (2020-2031)
• 6.3 US & Canada Synthetic Peptide Vaccine Market Size by Country
  • 6.3.1 US & Canada Synthetic Peptide Vaccine Revenue by Country (2020-2031)
  • 6.3.2 US & Canada Synthetic Peptide Vaccine Sales by Country (2020-2031)
  • 6.3.3 US
  • 6.3.4 Canada
  • 6.3.5 Mexico

7 EUROPE

• 7.1 Europe Synthetic Peptide Vaccine Market Size by Type
  • 7.1.1 Europe Synthetic Peptide Vaccine Sales by Type (2020-2031)
  • 7.1.2 Europe Synthetic Peptide Vaccine Revenue by Type (2020-2031)
• 7.2 Europe Synthetic Peptide Vaccine Market Size by Application
  • 7.2.1 Europe Synthetic Peptide Vaccine Sales by Application (2020-2031)
  • 7.2.2 Europe Synthetic Peptide Vaccine Revenue by Application (2020-2031)
• 7.3 Europe Synthetic Peptide Vaccine Market Size by Country
  • 7.3.1 Europe Synthetic Peptide Vaccine Revenue by Country (2020-2031)
  • 7.3.2 Europe Synthetic Peptide Vaccine Sales by Country (2020-2031)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 CHINA

• 8.1 China Synthetic Peptide Vaccine Market Size by Type
  • 8.1.1 China Synthetic Peptide Vaccine Sales by Type (2020-2031)
  • 8.1.2 China Synthetic Peptide Vaccine Revenue by Type (2020-2031)
• 8.2 China Synthetic Peptide Vaccine Market Size by Application
  • 8.2.1 China Synthetic Peptide Vaccine Sales by Application (2020-2031)
  • 8.2.2 China Synthetic Peptide Vaccine Revenue by Application (2020-2031)

9 ASIA (EXCLUDING CHINA)

• 9.1 Asia Synthetic Peptide Vaccine Market Size by Type
  • 9.1.1 Asia Synthetic Peptide Vaccine Sales by Type (2020-2031)
  • 9.1.2 Asia Synthetic Peptide Vaccine Revenue by Type (2020-2031)
• 9.2 Asia Synthetic Peptide Vaccine Market Size by Application
  • 9.2.1 Asia Synthetic Peptide Vaccine Sales by Application (2020-2031)
  • 9.2.2 Asia Synthetic Peptide Vaccine Revenue by Application (2020-2031)
• 9.3 Asia Synthetic Peptide Vaccine Market Size by Region
  • 9.3.1 Asia Synthetic Peptide Vaccine Revenue by Region (2020-2031)
  • 9.3.2 Asia Synthetic Peptide Vaccine Sales by Region (2020-2031)
  • 9.3.3 Japan
  • 9.3.4 South Korea
  • 9.3.5 China Taiwan
  • 9.3.6 Southeast Asia
  • 9.3.7 India

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

• 10.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Synthetic Peptide Vaccine Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2020-2031)
  • 10.3.2 Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2020-2031)
  • 10.3.3 Latin America
  • 10.3.4 Middle East
  • 10.3.5 Africa

11 CORPORATE PROFILE

• 11.1 United Biomedical
  • 11.1.1 United Biomedical Company Information
  • 11.1.2 United Biomedical Overview
  • 11.1.3 United Biomedical Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 United Biomedical Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 United Biomedical Recent Developments
• 11.2 CAHIC
  • 11.2.1 CAHIC Company Information
  • 11.2.2 CAHIC Overview
  • 11.2.3 CAHIC Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 CAHIC Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.3 Xinjiang Tecon
  • 11.3.1 Xinjiang Tecon Company Information
  • 11.3.2 Xinjiang Tecon Overview
  • 11.3.3 Xinjiang Tecon Synthetic Peptide Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Xinjiang Tecon Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.4 ISA Pharmaceuticals
  • 11.4.1 ISA Pharmaceuticals Company Information
  • 11.4.2 ISA Pharmaceuticals Overview
  • 11.4.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.5 Lytix Biopharma
  • 11.5.1 Lytix Biopharma Company Information
  • 11.5.2 Lytix Biopharma Overview
  • 11.5.3 Lytix Biopharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.6 Merck
  • 11.6.1 Merck Company Information
  • 11.6.2 Merck Overview
  • 11.6.3 Merck Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.7 OncoTherapy Science
  • 11.7.1 OncoTherapy Science Company Information
  • 11.7.2 OncoTherapy Science Overview
  • 11.7.3 OncoTherapy Science Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.8 Circio
  • 11.8.1 Circio Company Information
  • 11.8.2 Circio Overview
  • 11.8.3 Circio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.4 Circio Recent Developments
• 11.9 Stemline Therapeutics
  • 11.9.1 Stemline Therapeutics Company Information
  • 11.9.2 Stemline Therapeutics Overview
  • 11.9.3 Stemline Therapeutics Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• 11.10 Treos Bio
  • 11.10.1 Treos Bio Company Information
  • 11.10.2 Treos Bio Overview
  • 11.10.3 Treos Bio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

• 12.1 Synthetic Peptide Vaccine Industry Chain Analysis
• 12.2 Synthetic Peptide Vaccine Key Raw Material
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Synthetic Peptide Vaccine Production Mode & Process
• 12.4 Synthetic Peptide Vaccine Sales and Marketing

13 SYNTHETIC PEPTIDE VACCINE MARKET DYNAMICS

• 13.1.1 Synthetic Peptide Vaccine Industry Trends
• 13.1.2 Synthetic Peptide Vaccine Market Drivers
• 13.1.3 Synthetic Peptide Vaccine Market Challenges
• 13.1.4 Synthetic Peptide Vaccine Market Restraints

14 KEY FINDINGS IN THE GLOBAL SYNTHETIC PEPTIDE VACCINE STUDY

15 APPENDIX

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer 127